- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Hormonal Imbalance in Adult Survivors of Pediatric Cranial Tumors Reported
Investigators at St. Jude Children's Research Hospital found that decades after undergoing cranial irradiation for childhood cancer, adult survivors remain at risk for pituitary hormone deficiencies that may diminish their health and quality of life.
Investigators at St. Jude assessed the levels of pituitary hormones growth hormone, luteinizing hormone/follicle-stimulating hormone, thyroid-stimulating hormone, and adrenocorticotropic hormone) in adults who had undergone cranial radiotherapy following a childhood cancer.
The 748 participants in the study who had received cranial radiotherapy, included 394 men (mean age 34.2 years) who were observed for a mean of 27.3 years. The study examined the associations between demographic and treatment-related risk factors and pituitary deficiencies, as well as associations between untreated deficiencies and cardiovascular health, bone mineral density, and physical fitness.
The authors observed anterior pituitary deficits following cranial radiotherapy. Additonally, continued development of growth hormone deficiency and deficiencies in luteinizing hormone/follicle-stimulating hormone were observed, with possible associations between nontreatment of these conditions and poor health outcomes.
The paper has been published in The Journal of Clinical Oncology: http://bit.ly/1JmmBji
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
